Ciclosporin A potentiates venetoclax efficacy in FLT3‐ITD AML by targeting the NFATC1–AKT–mTOR–BCL‐2/MCL‐1 signaling axis

Yu Luo(Chongqing Medical University), Chengfang Zhou(Army Medical University), Mei Kuang(Army Medical University), Jieping Chen(Army Medical University), Wang Li(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jianming Wang(Army Medical University), Siqi Luo(Dalian Medical University), Yinghao Fu(Chongqing Medical University), Shuangnian Xu(Army Medical University)
British Journal of Haematology
May 6, 2025
Cited by 5


Related Papers